has semaglutide cause cancer in humans Glucagon-like peptide-1 medicines and New Research Challenges Fears of

The B12 is along for the ride

After almost two decades of the clinical use of GLP-1 for T2D and 10 years after the first GLP-1 medicine, liraglutide, was approved for #weight loss in people with obesity, the next decade may bring even greater progress, introducing more powerful GLP-1 medicines while expanding the utility of GLP-1 therapeutics beyond currently established #cardiometabolic disorders #GLP #obesity #publichealth #medicines #pharmacology

pmid:29482528 54

Within cellular biology research, FOXO proteins are known to participate in signalling networks that regulate gene expression related to cellular stress responses, metabolic activity and programmed cellular processes